Medicines RVO/3439/2025: Antacids, Local and General Anesthetics, Systemic Antifungals for FNsP F. D. Roosevelt Banská Bystrica

This public procurement concerns the supply of medicines for the F. D. Roosevelt University Hospital in Banská Bystrica, categorized under reference RVO/3439/2025. The scope includes antacids, local and general anesthetics, and systemic antifungals. The procurement is divided into 50 lots, and bidders have the option to submit offers for the entire scope, individual lots, or multiple lots as specified in the tender documentation. The hospital requires a reliable supply of these essential medications to ensure the continuity of patient care across various medical departments. Bidders are expected to provide high-quality pharmaceutical products that meet all regulatory requirements and pharmacopeial standards. The tender documents will detail the specific medications, quantities, packaging, delivery schedules, and any special storage or handling conditions. The evaluation criteria will focus on the quality of the offered medicines, the supplier's ability to meet delivery requirements, compliance with regulatory standards, and the proposed pricing. This procurement is critical for the hospital's ability to provide effective medical treatment to its patients.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Pharmaceuticals. Located in Slovakia, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 3.8 million.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.